120 related articles for article (PubMed ID: 9259184)
1. Decreased PMN accumulation and glomerular damage by clodronate liposome treatment in PMN-dependent anti-GBM nephritis in mice.
Feith GW; Bogman MJ; Assmann KJ; van Gompel AP; Schalkwijk J; van Rooijen N; Koene RA
Exp Nephrol; 1997; 5(4):301-4. PubMed ID: 9259184
[TBL] [Abstract][Full Text] [Related]
2. Different mediator systems in biphasic heterologous phase of anti-GBM nephritis in mice.
Feith GW; Assmann KJ; Bogman MJ; van Gompel AP; Schalkwijk J; Koene RA
Nephrol Dial Transplant; 1996 Apr; 11(4):599-607. PubMed ID: 8671846
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A reduces albuminuria in experimental anti-GBM nephritis independently from changes in GFR.
Schrijver G; Assmann KJ; Wetzels JF; Berden JH
Nephrol Dial Transplant; 1995; 10(7):1149-54. PubMed ID: 7478116
[TBL] [Abstract][Full Text] [Related]
4. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
Isome M; Fujinaka H; Adhikary LP; Kovalenko P; El-Shemi AG; Yoshida Y; Yaoita E; Takeishi T; Takeya M; Naito M; Suzuki H; Yamamoto T
Nephrol Dial Transplant; 2004 Dec; 19(12):2997-3004. PubMed ID: 15574997
[TBL] [Abstract][Full Text] [Related]
5. Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: evidence for dose-dependent, direct antibody and complement-induced, cell-independent injury.
Boyce NW; Holdsworth SR
J Immunol; 1985 Dec; 135(6):3918-21. PubMed ID: 4067309
[TBL] [Abstract][Full Text] [Related]
6. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
[TBL] [Abstract][Full Text] [Related]
7. Antiglomerular basement membrane nephritis in beige mice. Deficiency of leukocytic neutral proteinases prevents the induction of albuminuria in the heterologous phase.
Schrijver G; Schalkwijk J; Robben JC; Assmann KJ; Koene RA
J Exp Med; 1989 Apr; 169(4):1435-48. PubMed ID: 2538553
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation within Bowman's capsule in mice.
Morley AR; Wheeler J
J Pathol; 1985 Apr; 145(4):315-27. PubMed ID: 3889246
[TBL] [Abstract][Full Text] [Related]
9. Antibody-dependent cellular cytotoxicity and chemiluminescence as a tool for studying the mechanism of anti-glomerular basement membrane nephritis. The role of the cytotoxic potential of polymorphonuclear granulocytes and monocytes.
Mossmann H; Hoyer B; Walz W; Himmelspach K; Hammer DK
Immunology; 1984 Nov; 53(3):545-52. PubMed ID: 6490096
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of glomerular neutrophil influx after lipopolysaccharide in antibody-mediated injury.
Savige JA; Evans DJ; Rees AJ
Clin Exp Immunol; 1988 Jul; 73(1):134-8. PubMed ID: 3168328
[TBL] [Abstract][Full Text] [Related]
11. Distinctive roles of neutrophils and monocytes in anti-thy-1 nephritis.
Westerhuis R; van Straaten SC; van Dixhoorn MG; van Rooijen N; Verhagen NA; Dijkstra CD; de Heer E; Daha MR
Am J Pathol; 2000 Jan; 156(1):303-10. PubMed ID: 10623679
[TBL] [Abstract][Full Text] [Related]
12. Antiglomerular basement membrane nephritis in the mouse. Study on the role of complement in the heterologous phase.
Schrijver G; Assmann KJ; Bogman MJ; Robben JC; de Waal RM; Koene RA
Lab Invest; 1988 Oct; 59(4):484-91. PubMed ID: 3050274
[TBL] [Abstract][Full Text] [Related]
13. Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1.
Tomosugi NI; Cashman SJ; Hay H; Pusey CD; Evans DJ; Shaw A; Rees AJ
J Immunol; 1989 May; 142(9):3083-90. PubMed ID: 2785133
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical characterization of glomerular inflammatory cells and expression of adhesion molecules in anti-glomerular basement membrane (anti-GBM) glomerulonephritis induced in WKY rats with monoclonal anti-GBM antibodies of different subclasses.
Kado T; Kohda T; Okada S; Hayashi A; Utsunomiya Y; Kanzaki S; Sado Y; Yamamoto T
Pathol Int; 2006 Feb; 56(2):55-61. PubMed ID: 16445816
[TBL] [Abstract][Full Text] [Related]
15. Resistance of CD28-deficient mice to autologous phase of anti-glomerular basement membrane glomerulonephritis.
Nitta K; Horita S; Ogawa S; Matsumoto M; Hara Y; Okano K; Hayashi T; Abe R; Nihei H
Clin Exp Nephrol; 2003 Jun; 7(2):104-12. PubMed ID: 14586728
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.
Wolf D; Hochegger K; Wolf AM; Rumpold HF; Gastl G; Tilg H; Mayer G; Gunsilius E; Rosenkranz AR
J Am Soc Nephrol; 2005 May; 16(5):1360-70. PubMed ID: 15788479
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes.
Yang R; Otten MA; Hellmark T; Collin M; Björck L; Zhao MH; Daha MR; Segelmark M
Nephrol Dial Transplant; 2010 Aug; 25(8):2479-86. PubMed ID: 20219834
[TBL] [Abstract][Full Text] [Related]
18. Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomes.
Tomita N; Morishita R; Yamamoto K; Higaki J; Dzau VJ; Ogihara T; Kaneda Y
J Gene Med; 2002; 4(5):527-35. PubMed ID: 12221646
[TBL] [Abstract][Full Text] [Related]
19. [Production of reactive oxygen species and scavenger treatment in nephrotoxic nephritis].
Nakamura K
Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):761-72. PubMed ID: 1479715
[TBL] [Abstract][Full Text] [Related]
20. The mediation of the localization of polymorphonuclear leucocytes in glomeruli during the autologous phase of nephrotoxic nephritis.
Sindrey M; Naish P
Clin Exp Immunol; 1979 Mar; 35(3):350-5. PubMed ID: 455777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
